Stacley Au

Title: Stacley Au: Innovator in Antifungal Gel Formulations

Introduction

Stacley Au is a notable inventor based in Tonawanda, NY (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in antifungal treatments. With a total of 2 patents, his work focuses on creating effective and stable gel formulations for topical use.

Latest Patents

Stacley Au's latest patents include innovative antifungal gel formulations. The first patent describes stable anhydrous gel formulations for topical antifungal use, which contain an imidazole, a steroid, a co-solvent system comprising monohydric and dihydric alcohols, and a hydroxyalkylcellulose gellant. The second patent presents an antifungal gel composition that is effective at 0.2-2.0% by weight of an imidazole antifungal agent and 0.01-2.5% by weight of a 17-ester corticosteroid anti-inflammatory agent. This composition is designed for topical administration and is highly effective in treating fungal infections. It can be stored without refrigeration for extended periods without losing therapeutic effectiveness while maintaining the uniformity and stability of the gel.

Career Highlights

Stacley Au is currently employed at Bristol-Myers Squibb Company, where he continues to develop innovative pharmaceutical solutions. His work has contributed to advancements in antifungal treatments, showcasing his dedication to improving patient care through effective medication.

Collaborations

Stacley has collaborated with notable coworkers such as Jonas C. Wang and Bhiku Patel, further enhancing the research and development efforts within his team.

Conclusion

Stacley Au's contributions to antifungal gel formulations highlight his innovative spirit and commitment to advancing pharmaceutical science. His patents reflect a significant step forward in the treatment of fungal infections, ensuring that patients receive effective and stable therapies.